Not applicableStudy completedNCT01760759What this trial is testingAntiretroviral Therapy Adherence and Secondary Prevention of Human Immunodeficiency VirusWho this might be right forHIV UConn Health 104
Testing effectiveness (Phase 2)Looking for participantsNCT06580574What this trial is testingImmune Checkpoint Inhibitors for Organ Preservation in Non-metastatic dMMR/MSI-H Gastric or Colon CancersWho this might be right forGastric CancerColon CancerMSI-H+1 more Peking University 34
Large-scale testing (Phase 3)Study completedNCT04870333What this trial is testingPROphylaxis for paTiEnts at Risk of COVID-19 infecTion -VWho this might be right forCovid19 Cambridge University Hospitals NHS Foundation Trust 2,240
Testing effectiveness (Phase 2)Active Not RecruitingNCT05200559What this trial is testingT-regulatory Cell Depletion With E7777 Combined With Pembrolizumab in Recurrent or Metastatic Solid TumorsWho this might be right forEpithelial Ovarian Cancer Alexander B Olawaiye, MD 25
Early research (Phase 1)Study completedNCT00092937What this trial is testingUse of Busulfan as Conditioning Agent for a Second Stem Cell TransplantWho this might be right forGranulomatous DiseaseChronic National Institute of Allergy and Infectious Diseases (NIAID) 2
Testing effectiveness (Phase 2)WithdrawnNCT00008866What this trial is testingEffectiveness of Early or Delayed Addition of Hydroxyurea to a Three-Drug Anti-HIV Drug Combination Including Didanosine, in Advanced HIV Patients Who Failed a First or Second Anti-HIV Triple-Drug TherapyWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)UnknownNCT03018405What this trial is testingA Dose Escalation Phase I Study to Assess the Safety and Clinical Activity of Multiple Cancer IndicationsWho this might be right forAcute Myeloid Leukemia/Myelodysplastic SyndromeMultiple Myeloma (MM) Celyad Oncology SA 146
Not applicableStudy completedNCT02888535What this trial is testingIntensive Care Unit and Secondary and Primary Immune DeficiencyWho this might be right forPrimary Immune Deficiency Disorder University Hospital, Caen 16
Not applicableStudy completedNCT00517803What this trial is testingMicronutrient Supplemented Probiotic Yogurt for HIV/AIDS and Other ImmunodeficienciesWho this might be right forHIV InfectionsCancer, Second Primary London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 24
Early research (Phase 1)Study completedNCT03329950What this trial is testingCDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced MalignanciesWho this might be right forMelanomaNon-small Cell Lung CancerBreast Cancer+23 more Celldex Therapeutics 132
Testing effectiveness (Phase 2)Study completedNCT03991013What this trial is testingTenofovir-lamivudine-dolutegravir Combination as Second-line ART: a Randomised Controlled TrialWho this might be right forHIV Infections University of Cape Town 192
Not applicableStudy completedNCT00005762What this trial is testingDrug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative VolunteersWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 90
Early research (Phase 1)Study completedNCT00295971What this trial is testingDonor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency DiseaseWho this might be right forCongenital Amegakaryocytic ThrombocytopeniaLeukemiaMyelodysplastic Syndromes+1 more University of California, San Francisco 21
Not applicableEnded earlyNCT00290628What this trial is testingDonor Umbilical Cord Blood Transplant in Treating Patients With Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersDiamond-blackfan AnemiaFanconi Anemia+6 more Masonic Cancer Center, University of Minnesota 43
Post-approval studies (Phase 4)Study completedNCT00627055What this trial is testingSecond-line Therapy Antiretroviral in Patients Who Failed Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) - Based RegimensWho this might be right forHIV Infections The HIV Netherlands Australia Thailand Research Collaboration 200
Not applicableActive Not RecruitingNCT05699785What this trial is testingComparison of Inflammatory Markers and Incidence of Comorbidities in Patients on Antiretroviral Therapy With Second-generation Anti-integrase Drugs on Triple Versus Dual TherapyWho this might be right forHiv Centre Hospitalier Universitaire de Nice 500
Not applicableStudy completedNCT01414660What this trial is testingEvolution of Interleukin 7, Fat Mass and Metabolic Profile Before and After TransplantationWho this might be right forImmunodeficiency Secondary to Organ Transplantation University Hospital, Lille 49
Not applicableStudy completedNCT03135067What this trial is testingSecondary Distribution of HIV Self-tests: an Innovative Strategy for Promoting Partner Testing and Reducing HIV RiskWho this might be right forHuman Immunodeficiency Virus University of Pennsylvania 2,102
Large-scale testing (Phase 3)UnknownNCT01108614What this trial is testingInjecting Drug Use Community Intervention TrialWho this might be right forHIVHepatitis CSyphilis+2 more National Center for AIDS/STD Control and Prevention, China CDC 12,000
Not applicableStudy completedNCT04246840What this trial is testingStudy Through Imaging of Visceral Lymphoid Organs in Patients With SCID Who Have Recieved Bone Marrow AllograftWho this might be right forSevere Combined Immunodeficiency Association Pour l'Aide a la Recherche en Immunologie Pediatrique 18